This inventor holds 1 USPTO granted patent. Top assignee: Terumo Kabushiki Kaisha. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Ryouichi Yoshinari: Innovator in Blood Sugar Management
Introduction
Ryouichi Yoshinari, an inventive mind from Hadano, Japan, is recognized for his contribution to healthcare technology. He has developed a patented system that enhances the safety and accuracy of blood glucose monitoring in hospital environments.
Latest Patents
Yoshinari holds a patent for a "Blood Sugar Measured Level Management System and Blood Sugar Level Measurement Apparatus." This invention addresses the critical issue of preventing accidents that can occur when multiple blood glucose meters are utilized within a hospital ward. The device features a nickname area stored in nonvolatile memory that can be updated externally. When powered on, the glucose meter displays its nickname, thereby reducing the likelihood of operational errors. It also includes a measurement data managing device that matches blood glucose meter serial numbers with their corresponding nicknames, ensuring accurate communication and data management.
Career Highlights
Currently, Ryouichi Yoshinari is associated with Terumo Kabushiki Kaisha, a prominent company in the healthcare sector known for developing innovative medical technologies. His work focuses on improving patient safety through effective management of medical equipment.
Collaborations
Yoshinari collaborates with notable colleagues, including Koichiro Asama and Yoshihisa Sugawara. Together, they contribute to advancements in medical technology and patient care, leveraging their expertise to drive innovation within the healthcare industry.
Conclusion
Ryouichi Yoshinari's commitment to enhancing medical device functionality exemplifies the significant impact that innovative thinking can have on healthcare. His patent serves as a vital step forward in ensuring patient safety and precision in blood glucose management, marking him as a notable inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
